MENU
ABOS
AS OF
Nov 13 closing price
Price
$1.81
Change
-$0.14 (-7.18%)
Capitalization
109.64M
136 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
ABOS
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Acumen Pharmaceuticals (ABOS) Earnings Date & Reports

Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease... Show more

A.I. Advisor
published Earnings

ABOS is expected to report earnings to rise 21.09% to -53 cents per share on March 30

Acumen Pharmaceuticals ABOS Stock Earnings Reports
Q4'25
Est.
$-0.53
Q3'25
Beat
by $0.16
Q2'25
Missed
by $0.17
Q1'25
Beat
by $0.03
Q4'24
Missed
by $0.13
The last earnings report on November 12 showed earnings per share of -43 cents, beating the estimate of -60 cents. With 160.90K shares outstanding, the current market capitalization sits at 109.64M.
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
ABOS
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ABOS showed earnings on November 12, 2025. You can read more about the earnings report here.
View AI-Driven Trading for ABOS
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
427 Park Street
Phone
+1 434 297-1000
Employees
52
Web
https://www.acumenpharm.com